Clinical Trial Update: GRoningen Early-PD Ambroxol Treatment [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Ambroxol treatment in Parkinson's disease (Phase 2/3) sponsored by University Medical Center Groningen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ambroxol (Ambroxol)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Parkinson, Parkinson Disease | Phase 2, Phase 3 | Status: UNKNOWN